Locations:
Search IconSearch

Tag: acute myeloid leukemia

23-CNR-4419109-CQD-Hero-650×450 Dr Sauter
December 11, 2023/Cancer/Research

Cell Therapy Offers New Hope for Refractory/Relapsed AML

Investigational chimeric antigen receptor natural killer cell therapy NKX101 associated with promising early response in patients with relapsed/refractory acute myeloid leukemia

23-CNR-4044609-CQD-Hero-650×450 AML study
October 20, 2023/Cancer/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad